Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness
Authors:
Open Access
- 2 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 27 (1) , 123-139
Abstract
Pituitary neuroendocrine tumors, PitNETs, are often aggressive and precipitate in distant metastases that are refractory to current therapies. However, the molecular mechanism in PitNETs' aggressiveness is not well understood. Developmental pluripotency-associated 4 (DPPA4) is known as a stem cell regulatory gene and overexpressed in certain cancers, but its function in the context of PitNETs' aggressiveness is not known. We employed both rat and human models of PitNETs. In the rat pituitary tumor model (RPT), we used prenatal-alcohol-exposed (PAE) female Fischer rats which developed aggressive PitNETs following estrogen treatment, while in the human pituitary tumor (HPT) model, we used aggressively proliferative cells from pituitary tumors of patients undergone surgery. Various molecular, cellular, and epigenetic techniques were used to determine the role of DPPA4 in PitNETs’ aggressiveness. We show that DPPA4 is overexpressed in association with increased cell stemness factors in aggressive PitNETs of PAE rats and of human patients. Gene-editing experiments demonstrate that DPPA4 increases the expression of cell stemness and tumor aggressiveness genes and promotes proliferation, colonization, migration, and tumorigenic potential of PitNET cells. ChIP assays and receptor antagonism studies reveal that DPPA4 binds to canonical WINTs promoters and increases directly or indirectly the Wnt/β-catenin control of cell stemness, tumor growth, and aggressiveness of PitNETs. Epigenetic studies show involvement of histone methyltransferase in alcohol activation of DPPA4. These findings support a role of DPPA4 in tumor stemness and aggressiveness and provide a preclinical rationale for modulating this stemness regulator for the treatment of PitNETs.Keywords
Funding Information
- National Institute of Health (R01 AA11591, NJ06160)
This publication has 51 references indexed in Scilit:
- Opioid Withdrawal Produces Sex-Specific Effects on Fentanyl-Versus-Food Choice and Mesolimbic TranscriptionBiological Psychiatry Global Open Science, 2021
- Aggressive prolactinomas: how to manage?Pituitary, 2019
- Cancer stem cells (CSCs) in cancer progression and therapyJournal of Cellular Physiology, 2018
- IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograftCancer Letters, 2018
- Establishment of a protocol to extend the lifespan of human hormone-secreting pituitary adenoma cellsEndocrine, 2017
- Identification of DPPA4 and DPPA2 as a novel family of pluripotency-related oncogenesStem Cells, 2013
- Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysisPituitary, 2011
- The prolactinomaBest Practice & Research Clinical Endocrinology & Metabolism, 2009
- Identification of DPPA4 and other genes as putative Sox2:Oct‐3/4 target genes using a combination of in silico analysis and transcription‐based assaysJournal of Cellular Physiology, 2008
- Expression of P27 kip 1 and Ki-67 in Pituitary Adenomas: An Investigation of Marker of Adenoma InvasivenessActa Neurochirurgica, 1999